Frits‐Axel Wiesel

Uppsala University Hospital — Sweden

Medicine · Health Sciences

29h-index3.1kcitations78works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Schizophrenia research and treatment(23), Neuroscience and Neuropharmacology Research(19), Neurotransmitter Receptor Influence on Behavior(16), Receptor Mechanisms and Signaling(9), Tryptophan and brain disorders(9)

Publications78 total

Deconstructing the ‘black box’ of the Camberwell assessment of need score in mental health services evaluation
Social Psychiatry and Psychiatric Epidemiology·2008· 29 cited
Functional characterization of tyrosine transport in fibroblast cells from healthy controls
Neuroscience Letters·2008· 24 cited
[Schizophrenia is a systemic disease. Genetic mechanisms and environmental factors interact in the disease development].
PubMed·2007· 1 cited
Aberrant amino acid transport in fibroblasts from children with autism
Neuroscience Letters·2007· 33 cited
The Camberwell assessment of need as an outcome measure in routine mental health care
Social Psychiatry and Psychiatric Epidemiology·2006· 62 cited
Tyrosine transport in fibroblasts from healthy volunteers and patients with schizophrenia
Neuroscience Letters·2005· 15 cited
Support for limited brain availability of tyrosine in patients with schizophrenia
The International Journal of Neuropsychopharmacology·2005· 21 citedOpen Access
The Need of Support and Service Questionnaire (NSSQ): A brief scale to assess needs in clients with long-term mental disabilities
Nordic Journal of Psychiatry·2005· 13 cited
Changes in needs of support and service among long-term mentally disabled clients
2005
Factor structure in the Camberwell Assessment of Need
The British Journal of Psychiatry·2004· 60 citedOpen Access
Amino-acid transport in schizophrenia
2004
Clients with long-term mental disabilities in a Swedish county—conditions of life, needs of support and unmet needs of service provided by the public health and social service sectors
European Psychiatry·2003· 20 cited
No association between a putative functional promoter variant in the dopamine ??-hydroxylase gene and schizophrenia
Psychiatric Genetics·2003· 14 cited
Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis
Psychiatric Genetics·2003· 110 cited
Association study between dopamine D<sub>3</sub> receptor gene variant and personality traits
American Journal of Medical Genetics Part B Neuropsychiatric Genetics·2002· 19 cited
Trends in the drug treatment of schizophrenia
European Psychiatry·2002
Aberrant Tyrosine Transport Across the Cell Membrane in Patients With Schizophrenia
Archives of General Psychiatry·2001· 40 cited
D2 and 5HT2A receptor occupancy of different doses of quetiapine in schizophrenia: a PET study
European Neuropsychopharmacology·2001· 141 cited
Neuromuscular and psychomotor abnormalities in patients with schizophrenia and their first-degree relatives
Journal of Psychiatric Research·2000· 14 cited
Muscle biopsy, macro EMG, and clinical characteristics in patients with schizophrenia
Biological Psychiatry·2000· 28 cited
page 1 of 4Next →

Frequent Co-authors

L. Bjerkenstedt(15), Göran Sedvall(12), Gunnar Edman(9), Lena Flyckt(7), Gunnel Alfredsson(7), Nikolaos Venizelos(6), Anna Nordström(5), Lars Farde(4), Kaj Forslund(4), Lars Hagenfeldt(4), G�ran Sedvall(3), Henrik Nybäck(3), Erik G. Jönsson(3), Marc‐Antoine Crocq(3), Marja Mattila‐Evenden(3), Gunnar Rylander(3), Erik Wennström(3), Paul Skett(3), B. Fyrö(2), Birgitta Wode‐Helgodt(2)